Standard BioTools Inc.
LAB
$0.68
$0.034.47%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 476.72M | 455.18M | 187.58M | 194.90M | 237.09M |
| Total Receivables | 15.75M | 41.64M | 13.43M | 13.54M | 14.61M |
| Inventory | 17.10M | 18.59M | 19.98M | 25.42M | 24.17M |
| Prepaid Expenses | 7.30M | 6.05M | 4.87M | 7.91M | 7.08M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 228.41M | 230.68M | 223.09M |
| Total Current Assets | 516.87M | 521.45M | 454.26M | 472.44M | 506.04M |
|
|
|||||
| Total Current Assets | 516.87M | 521.45M | 454.26M | 472.44M | 506.04M |
| Net Property, Plant & Equipment | 39.55M | 42.65M | 46.01M | 44.19M | 47.25M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.53M | 3.66M | 41.78M | 3.52M | 3.68M |
| Total Assets | 627.22M | 639.11M | 567.75M | 539.64M | 556.97M |
|
|
|||||
| Total Accounts Payable | 9.55M | 8.01M | 5.41M | 6.62M | 7.33M |
| Total Accrued Expenses | 23.91M | 9.49M | 25.24M | 22.71M | 21.59M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 5.62M | 5.54M | 5.49M | 5.11M | 5.09M |
| Total Finance Division Other Current Liabilities | 17.72M | 19.17M | 72.17M | 73.52M | 64.01M |
| Total Other Current Liabilities | 17.72M | 19.17M | 72.17M | 73.52M | 64.01M |
| Total Current Liabilities | 56.80M | 42.20M | 108.31M | 107.97M | 98.02M |
|
|
|||||
| Total Current Liabilities | 56.80M | 42.20M | 108.31M | 107.97M | 98.02M |
| Long-Term Debt | 299.00K | 299.00K | 299.00K | 299.00K | 299.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 22.17M | 23.65M | 25.04M | 21.98M | 23.22M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 7.98M | 11.84M | 9.82M | 9.74M | 10.88M |
| Total Liabilities | 87.25M | 77.99M | 143.46M | 139.98M | 132.43M |
|
|
|||||
| Common Stock & APIC | 1.75B | 1.74B | 1.73B | 1.73B | 1.72B |
| Retained Earnings | -1.16B | -1.13B | -1.26B | -1.28B | -1.25B |
| Treasury Stock & Other | -45.28M | -46.98M | -47.96M | -46.94M | -48.40M |
| Total Common Equity | 539.97M | 561.12M | 424.29M | 399.66M | 424.54M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 539.97M | 561.12M | 424.29M | 399.66M | 424.54M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 539.97M | 561.12M | 424.29M | 399.66M | 424.54M |
|
|
|||||